Back to discover
Disease

Campylobacter Infections

Late-stage therapeutic developmentEmerging researchRising momentum
3
Publications
2
Clinical trials
2024
Latest publication

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial with recent milestones (1 completed or reporting results).

Clinical trials

2 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Research activity

3 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20022024
Major themes4
  • Campylobacter1
  • Campylobacter Infections1
  • Communicable Diseases1
  • Gastroenteritis1
Leading journals3
  • BMC public health1
  • Gut1
  • PLoS computational biology1
Leading researchers8
  • Adak GK1
  • Brooke RJ1
  • Cassini A1
  • Cook AJC1
  • Derks G1
  • Fèvre EM1
  • Fleming LE1
  • French N1
Affiliations (unnormalised)6
  • Australian National University1
  • Centre for Immunity1
  • Centre for Mathematical and Computational Biology1
  • European Centre for Environment and Human Health1
  • Institute for Environmental Design and Engineering1
  • Institute for Sustainability1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Infections with bacteria of the genus CAMPYLOBACTER.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.